Compare Edwards Lifesciences Corporation Common Stock (EW) vs State Street SPDR S&P Homebuilders ETF (XHB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs State Street SPDR S&P Homebuilders ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while State Street SPDR S&P Homebuilders ETF trades at $95.59 (market cap $1.53B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 32.3× State Street SPDR S&P Homebuilders ETF's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, State Street SPDR S&P Homebuilders ETF nearer its low. Which is the better fit depends on your goals.
| EW | XHB | |
|---|---|---|
Market Cap | $49.44B | $1.53B |
Volume | 3,508,027 | 2,228,322 |
Sector | Health | Broad Market / Factor |
52-Week High | $95.18 | $121.36 |
52-Week Low | $72.65 | $94.86 |
Enterprise Value | $45.90B | — |
Typical Hold Time | — | 33 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XHB (SPDR S&P Homebuilders ETF) trades at $94.89, down 2.55% today amid a bearish technical signal from moving averages, though oscillators are neutral. The ETF, tracking homebuilder stocks, faces headwinds from rising mortgage rates but benefits from positive housing legislation and institutional interest. Key support sits at $94, with resistance at $95.
Outlook is mixed: potential upside exists from housing policy tailwinds and undervalued sector signals, but high rates and volatile sales data pose near-term risks. Investors should weigh macroeconomic sensitivity against long-term housing demand drivers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About State Street SPDR S&P Homebuilders ETF
XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.
Read more on XHB →
